Factory 99% Docetaxel Powder CAS 114977-28-5 Chemical Intermediate Docetaxel

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A477
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Docetaxel
• CAS: 114977-28-5
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Anti-Cancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Docetaxel
Appearance	White Powder
CAS NO.	114977-28-5
Molecular Formula	C42H54N4O14
Storage	Keep in a cool, dry, dark location

 

Docetaxel is an injectable chemotherapy agent used to treat various types of cancer. It works by inhibiting the growth and division of cancer cells, leading to their eventual death. As a member of the taxane class, it targets microtubules within cells, disrupting their normal function and interfering with cell division.

 

1. Breast Cancer: Docetaxel is commonly used in combination with other drugs for the treatment of breast cancer, both in the adjuvant (post-surgery) and metastatic (advanced) settings.
2. Non-Small Cell Lung Cancer: It is also effective in treating non-small cell lung cancer, often in combination with cisplatin or carboplatin.
3. Prostate Cancer: In certain cases, docetaxel may be used to treat prostate cancer that has progressed despite hormone therapy.

1. Cell Division Inhibition: By binding to tubulin, docetaxel disrupts the formation of microtubules, which are essential for cell division. This leads to the arrest of cancer cell growth and proliferation.
2. Anti-Tumor Activity: Its anti-tumor activity is due to its ability to induce apoptosis (programmed cell death) in cancer cells, thereby reducing tumor size and progression.
3. Combination Therapy: Docetaxel is often used in combination with other chemotherapy drugs to enhance their effectiveness and broaden the range of cancers treated, leveraging its synergistic effects with other agents.